Skip to Content
Download as PDF

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

First Session, Forty-first Parliament, 2011-12

Chair: The Honourable KELVIN KENNETH OGILVIE


Wednesday, April 4, 2012
Wednesday, April 25, 2012
Thursday, April 26, 2012

Issue No. 14

Fourth, fifth and sixth meetings on:

Study on prescription pharmaceuticals in Canada


WITNESSES

Wednesday, April 4, 2012

Health Canada:

Paul Glover, Assistant Deputy Minister, Health Products and Food Branch (HPFB);

Barbara Sabourin, Director General, Therapeutic Products Directorate (TPD), HPFB;

Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, TPD, HPFB.

Office of the Auditor General of Canada:

Neil Maxwell, Assistant Auditor General;

Louise Dubé, Principal.

Wednesday, April 25, 2012

BIOTECanada:

Peter Brenders, President and Chief Executive Officer.

Hoffmann-La Roche Ltd.:

Nita Arora, Regional Head Affiliate Management, North America.

Rx&D:

Russell Williams, President;

Ken Hughes, Vice-President, Scientific and Regulatory Affairs.

Amgen Canada Inc.:

Dr. Clive Ward-Able, Executive Director, Research and Development.

Thursday, April 26, 2012

Canadian Stroke Consortium:

Dr. Mukul Sharma, Chairman of the Board.

Institutional Review Board Services:

Jack Corman, President.

Reformulary Group:

Helen Stevenson, President and Chief Executive Officer.


MEMBERS OF THE COMMITTEE

The Honourable Kelvin Kenneth Ogilvie, Chair

The Honourable Art Eggleton, P.C., Deputy Chair

and

The Honourable Senators:

Callbeck, Champagne, P.C., Cordy, *Cowan (or Tardif), Demers, Dyck, *LeBreton, P.C. (or Carignan), Martin, Merchant, Seidman, Seth, Verner, P.C.

*Ex officio members

(Quorum 4)

Changes in membership of the committee:

Pursuant to rule 85(4), membership of the committee was amended as follows:

The Honourable Senator Cordy replaced the Honourable Senator Campbell (March 29, 2012).